1. Signaling Pathways
  2. GPCR/G Protein
    Immunology/Inflammation
    Neuronal Signaling
  3. Histamine Receptor
  4. H2 Receptor Isoform

H2 Receptor

 

H2 Receptor Related Products (19):

Cat. No. Product Name Effect Purity
  • HY-A0077
    Perphenazine
    Antagonist 99.72%
    Perphenazine is an orally active dopamine receptor and histamine-1 receptor antagonist, with Ki values of 0.56 nM (D2), 0.43 nM (D3), 6 nM (5-HT2A), respectively.
  • HY-14289
    Cimetidine
    Modulator ≥98.0%
    Cimetidine (SKF-92334) is an orally active and inverse histamine H2 receptor antagonist with a Ki of 0.6 μM.
  • HY-10121
    Asenapine
    Antagonist 99.93%
    Asenapine (Org 5222), an atypical antipsychotic, is an antagonist of serotonin receptors (pKi: 8.4-10.5), adrenoceptors (pKi: 8.9-9.5), dopamine receptors (pKi: 8.9-9.4) and histamine receptors (pKi: 8.2-9.0).
  • HY-B0310
    Nizatidine
    Antagonist 99.19%
    Nizatidine is a potent and orally active histamine H2 receptor antagonist, can be used for the research of stomach and intestines ulcers.
  • HY-B1557
    Betazole
    Agonist
    Betazole (Ametazole), a pyrazole analogue of histamine, is an orally active histamine H2 receptor agonist.
  • HY-B0305A
    Roxatidine Acetate Hydrochloride
    Antagonist 98.08%
    Roxatidine Acetate Hydrochloride is a potent, selective, competitive and orally active histamine H2-receptor antagonist.
  • HY-101232
    Tiotidine
    Antagonist ≥99.0%
    Tiotidine (ICI 125211) is a potent and selective antagonist of histamine H2-receptor (pA2=7.3-7.8 for guinea-pig right atrium).
  • HY-14289A
    Cimetidine hydrochloride
    Antagonist
    Cimetidine (SKF-92334) hydrochloride is an orally active and inverse histamine H2 receptor antagonist with a Ki of 0.6 μM.
  • HY-101198
    Clobenpropit dihydrobromide
    Modulator
    Clobenpropit dihydrobromide is a potent histamine H3R antagonist/inverse agonist with a pEC50 of 8.07 for histamine H3LR.
  • HY-107563A
    ROS 234 dioxalate
    Antagonist
    ROS 234 dioxalate is a potent H3 antagonist, with a pKB of 9.46 for Guinea-pig ileum H3-receptor, a pKi of 8.90 for Rat cerebral cortex H3-receptor, and a ED50 of 19.12 mg/kg (ip) in ex vivo of Rat cerebral cortex.
  • HY-B1478
    Dimaprit dihydrochloride
    Agonist
    Dimaprit dihydrochloride is a selective histamine H2 receptor agonist, it also inhibits nNOS with an IC50 of 49 μM.
  • HY-B1557A
    Betazole dihydrochloride
    Agonist
    Betazole (Ametazole) dihydrochloride, a pyrazole analogue of histamine, is an orally active H2 receptor agonist.
  • HY-101052
    HTMT dimaleate
    Agonist
    HTMT (dimaleate) is a potent histamine H1 and H2 receptor agonist.
  • HY-108411
    Emedastine
    Antagonist ≥98.0%
    Emedastine is an orally active, selective and high affinity histamine H1 receptor antagonist with a Ki value of 1.3 nM.
  • HY-10121B
    Asenapine citrate
    Antagonist
    Asenapine citrate, an atypical antipsychotic, is an antagonist of serotonin receptors (pKi: 8.4-10.5), adrenoceptors (pKi: 8.9-9.5), dopamine receptors (pKi: 8.9-9.4) and histamine receptors (pKi: 8.2-9.0).
  • HY-B2178
    Emedastine difumarate
    Agonist
    Emedastine difumarate is an orally active, selective and high affinity histamine H1 receptor antagonist with a Ki value of 1.3 nM.
  • HY-B0305
    Roxatidine acetate
    Antagonist
    Roxatidine acetate is a potent, selective, competitive and orally active histamine H2-receptor antagonist.
  • HY-121450
    Lavoltidine
    Antagonist
    Lavoltidine (Loxtidine) is an an orally active, irreversible and highly potent histamine H2-receptor antagonist.
  • HY-B0693
    Ranitidine
    Antagonist
    Ranitidine is a potent, selective and orally active histamine H2-receptor antagonist with an IC50 of 3.3 μM that inhibits gastric secretion.